Queensland COVID-19 Vaccination (QoVAX) Safety and Efficacy Trial Program: Mixed Dose 1 and 2 Study
Not Applicable
Active, not recruiting
- Conditions
- COVID-19SARS-CoV-2Infection - Other infectious diseasesInflammatory and Immune System - Normal development and function of the immune systemRespiratory - Other respiratory disorders / diseases
- Registration Number
- ACTRN12621001524886
- Lead Sponsor
- Metro North Hospital and Health Service
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 586
Inclusion Criteria
People in Queensland 18 years of age and older, who have received two doses of BNT162b2 or ChAdOx1 COVID vaccines, the second of which was received between 120-180 days prior to giving consent,
Exclusion Criteria
1. Unable or decline to give informed consent
2. Have a contraindication to venepuncture
3. Insufficient literacy to read and understand the English or translated version of the participant information and consent forms who do not have a family member or interpreter to assist
4. Do not posses a smart phone or computer to access the participant information and complete the consent form and fill the questionnaire.
5. Are unable or unwilling to reach a pathology collection centre to donate samples.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method